Filtros de búsqueda

Lista de obras de Penelope Brock

A case series of pediatric primary central nervous system lymphoma: favorable outcome without cranial irradiation

artículo científico publicado en 2006

Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Euro

artículo científico publicado en 2017

Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens.

artículo científico publicado en 2016

Assessment of Primary Site Response in Children With High-Risk Neuroblastoma: An International Multicenter Study

artículo científico publicado en 2016

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.

artículo científico publicado en 2017

Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma

artículo científico publicado en 2009

Coagulopathy as a presenting feature of Wilms tumour

artículo científico publicado en 2004

Critical need for international consensus on ototoxicity assessment criteria

artículo científico publicado en 2010

Docetaxel in the Treatment of Children With Refractory or Relapsed Hepatoblastoma ⬇️

artículo científico publicado el 1 de octubre de 2012

Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study

artículo científico publicado en 2013

Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma – A phase II trial of the childhood liver tumour strategy group (SIOPEL)

artículo científico publicado en 2012

Excellent Outcome With Reduced Treatment in Infants With Nonmetastatic and Unresectable Neuroblastoma WithoutMYCNAmplification: Results of the Prospective INES 99.1

scientific article published on 20 December 2010

HOUT-11. ECONOMIC IMPACT OF SODIUM THIOSULFATE ON CISPLATIN-INDUCED HEARING LOSS

Hepatoblastoma in children aged less than six months at diagnosis: A report from the SIOPEL group.

artículo científico publicado en 2017

Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience

artículo científico publicado en 2008

Imaging characteristics of primary cranial Ewing sarcoma

artículo científico publicado en 2005

Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

artículo científico publicado en 2018

Interventions for cisplatin-induced hearing loss in children and adolescents with cancer

scientific article published on 31 May 2019

Intraocular Langerhans cell histiocytosis in a neonate resulting in bilateral loss of vision

scientific article published on 01 October 2006

Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1)

artículo científico publicado en 2020

Iontophoretic Transdermal Sampling of Iohexol as a Non-Invasive Tool to Assess Glomerular Filtration Rate

artículo científico publicado en 2014

MBCL-48. HEARING CHEMOPROTECTION WITH SODIUM THIOSULFATE (STS) IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH STANDARD RISK MEDULLOBLASTOMA

Mediastinal involvement in lymphangiomatosis: a previously unreported MRI sign

artículo científico publicado en 2011

Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report

artículo científico publicado en 2018

Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study

artículo científico publicado en 2014

Ototoxicity-induced hearing loss and quality of life in survivors of paediatric cancer

artículo científico publicado en 2020

Phase II study of high-dose cyclophosphamide in relapsing and/or resistant hepatoblastoma in children: a study from the SIOPEL group

artículo científico publicado en 2004

Pilot study of F(18)-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry

artículo científico publicado en 2010

Post-thaw viability of cryopreserved peripheral blood stem cells (PBSC) does not guarantee functional activity: important implications for quality assurance of stem cell transplant programmes.

artículo científico publicado en 2016

Primary Central Nervous System Lymphoma in Children: A Report of 12 Cases. ⬇️

artículo científico publicado en 2004

Prognostic stratification for children with hepatoblastoma: the SIOPEL experience

artículo científico publicado en 2012

Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study

artículo científico publicado en 2010

Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR.

artículo científico publicado en 2006

Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting

artículo científico publicado en 2017

Successful treatment of MYCN amplified, progressive stage 4S neuroblastoma in a neonate with hepatic artery embolization in addition to multimodality treatment

artículo científico publicado en 2006

Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study

artículo científico publicado en 2010

TPMT, COMT and ACYP2 genetic variants in paediatric cancer patients with cisplatin-induced ototoxicity.

artículo científico publicado en 2017

Ten challenges in the management of neuroblastoma.

artículo científico publicado en 2012

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD2 antibody ch14.18/CHO.

artículo científico publicado en 2017

Topotecan-Vincristine-Doxorubicin in Stage 4 High Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC - a SIOPEN Study

artículo científico publicado en 2017

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda